###begin article-title 0
###xml 18 44 18 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
CCL2 Responses to Mycobacterium tuberculosis Are Associated with Disease Severity in Tuberculosis
###end article-title 0
###begin p 1
Conceived and designed the experiments: ZH. Performed the experiments: ZH. Analyzed the data: ZH JMC MA RH. Contributed reagents/materials/analysis tools: HMD BJ MI MA. Wrote the paper: ZH JMC HMD RH.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 177 192 169 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 177 192 <span type="species:ncbi:1773">M. tuberculosis</span>
Leucocyte activating chemokines such as CCL2, CCL3, and CXCL8 together with proinflammatory IFNgamma, TNFalpha and downmodulatory IL10 play a central role in the restriction of M. tuberculosis infections, but is unclear whether these markers are indicative of tuberculosis disease severity.
###end p 3
###begin title 4
Methodology
###end title 4
###begin p 5
###xml 21 36 21 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 42 50 42 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 21 36 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 42 54 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 111 119 <span type="species:ncbi:9606">patients</span>
###xml 190 198 <span type="species:ncbi:9606">patients</span>
We investigated live M. tuberculosis- and M. bovis BCG- induced peripheral blood mononuclear cell responses in patients with tuberculosis (TB) and healthy endemic controls (ECs, n = 36). TB patients comprised pulmonary (PTB, n = 34) and extrapulmonary groups, subdivided into those with less severe localized extrapulmonary TB (L-ETB, n = 16) or severe disseminated ETB (D-ETB, n = 16). Secretion of CCL2, IFNgamma, IL10 and CCL3, and mRNA expression of CCL2, TNFalpha, CCL3 and CXCL8 were determined.
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 179 194 179 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 262 278 262 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis-</italic>
###xml 430 445 430 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 686 701 674 689 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 733 746 721 734 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 139 147 <span type="species:ncbi:9606">patients</span>
###xml 179 194 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 262 277 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 420 428 <span type="species:ncbi:9606">patients</span>
###xml 430 445 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
###xml 686 701 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis- and BCG- induced CCL2 secretion was significantly increased in both PTB and D-ETB (p<0.05, p<0.01) as compared with L-ETB patients. CCL2 secretion in response to M. tuberculosis was significantly greater than to BCG in the PTB and D-ETB groups. M. tuberculosis-induced CCL2 mRNA transcription was greater in PTB than L-ETB (p = 0.023), while CCL2 was reduced in L-ETB as compared with D-ETB (p = 0.005) patients. M. tuberculosis -induced IFNgamma was greater in L-ETB than PTB (p = 0.04), while BCG-induced IFNgamma was greater in L-ETB as compared with D-ETB patients (p = 0.036). TNFalpha mRNA expression was raised in PTB as compared with L-ETB group in response to M. tuberculosis (p = 0.02) and BCG (p = 0.03). Mycobacterium-induced CCL3 and CXCL8 was comparable between TB groups.
###end p 7
###begin title 8
Conclusions
###end title 8
###begin p 9
###xml 96 111 92 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 39 47 <span type="species:ncbi:9606">patients</span>
###xml 96 111 <span type="species:ncbi:1773">M. tuberculosis</span>
The increased CCL2 and TNFalpha in PTB patients may support effective leucocyte recruitment and M. tuberculosis localization. CCL2 alone is associated with severity of TB, possibly due to increased systemic inflammation found in severe disseminated TB or due to increased monocyte infiltration to lung parenchyma in pulmonary disease.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 126 129 126 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-World1">[1]</xref>
###xml 259 262 259 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Cagatay1">[2]</xref>
###xml 264 267 264 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Sharma1">[3]</xref>
###xml 350 353 350 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Harries1">[4]</xref>
###xml 301 329 <span type="species:ncbi:12721">human immunodeficiency virus</span>
###xml 331 334 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
Tuberculosis (TB) causes 1.8 million deaths annually with 9.27 million incident cases of which the majority (55%) are in Asia [1]. Although the primary disease remains at pulmonary sites, extrapulmonary disease is common especially in high TB burden settings [2], [3] or where there is a high rate of human immunodeficiency virus (HIV) co-prevalence [4].
###end p 11
###begin p 12
###xml 28 54 28 54 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 318 333 310 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 333 336 325 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Orme1">[5]</xref>
###xml 338 341 330 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Jo1">[6]</xref>
###xml 470 473 462 465 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Murray1">[7]</xref>
###xml 28 54 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 318 333 <span type="species:ncbi:1773">M. tuberculosis</span>
Protective immunity against Mycobacterium tuberculosis is dependent on the interplay between activated T cells, macrophages and other leucocytes. Proinflammatory cytokines such as, interferon gamma (IFN)-gamma, tumor necrosis factor-alpha (TNF)-alpha, interleukin (IL)-12 are essential for protective immunity against M. tuberculosis[5], [6]. IL-10 produced by macrophages is important in regulating the TH1 cytokine balance and down regulates proinflammatory responses [7].
###end p 12
###begin p 13
###xml 272 287 272 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 377 380 373 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Aarestrup1">[8]</xref>
###xml 382 385 378 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Bean1">[9]</xref>
###xml 876 880 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Algood1">[10]</xref>
###xml 881 885 862 866 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Ulrichs1">[13]</xref>
###xml 272 287 <span type="species:ncbi:1773">M. tuberculosis</span>
Small molecular weight (8-10 kDa) chemotactic cytokines or, chemokines are responsible for regulating the migration, trafficking, homing and activation of monocytes, macrophages and other leucocytes. An effective granulomatous response is essential for the restriction of M. tuberculosis infection. TNFalpha which is essential for macrophage activation and granuloma formation [8], [9] also influences the expression of chemokines by macrophages and mediates effective recruitment of leucocytes via the CC chemokines; CCL2 (monocyte chemoattractant protein (MCP)-1), CCL3 (macrophage inflammatory protein (MIP)- 1alpha), CCL4 (macrophage inflammatory protein (MIP)- 1beta), CCL5 (regulated on activation normal T cell expressed and secreted: RANTES) and CXC chemokines; CXCL8 (IL8), CXCL9 (monokine induced by IFNgamma: MIG) and CXCL10 (IFNgamma inducible 10kD protein: IP10) [10]-[13].
###end p 13
###begin p 14
###xml 276 280 276 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Penido1">[14]</xref>
###xml 324 328 324 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Saunders1">[15]</xref>
###xml 410 414 410 414 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kipnis1">[16]</xref>
###xml 516 520 512 516 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Dorner1">[17]</xref>
###xml 522 537 518 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 663 667 659 663 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Saukkonen1">[18]</xref>
###xml 819 823 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Moser1">[19]</xref>
###xml 825 829 821 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Walz1">[20]</xref>
###xml 926 930 922 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kurashima1">[21]</xref>
###xml 1001 1005 997 1001 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Park1">[22]</xref>
###xml 397 403 <span type="species:ncbi:10090">murine</span>
###xml 522 537 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 917 925 <span type="species:ncbi:9606">patients</span>
CCL2 and CCL3 are primarily secreted by monocytes, macrophages and dendritic cells. Responsiveness to CCL2 is dependent on its receptor CCR2, and CCL2 is a potent activator of cells which express CCR2 such as, monocytes, macrophages, CD4+ T cells and immature dendritic cells [14]. CCL2 is essential for granuloma formation [15] and plays a critical role in protection against tuberculosis in the murine model [16]. Chemokines CCL3, CCL4 and CCL5 function together with IFNgamma as type 1 proinflammatory chemokines [17]. M. tuberculosis infection of macrophages results in the induction of CCL3, CCL4 and CCL5 and these are required for inhibition of its growth [18]. CXC chemokines are predominantly secreted by polymorphonuclear cells and CXCL8 is the most potent chemotactic agent for neutrophils and T lymphocytes [19], [20]. It plays a role in the recruitment of lymphocytes and monocyte to pleural space in TB patients [21], as a result of CXCL8 production by macrophages and mesothelial cells [22].
###end p 14
###begin p 15
###xml 373 377 369 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan1">[23]</xref>
###xml 378 382 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan3">[25]</xref>
###xml 537 541 529 533 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Jamil1">[26]</xref>
###xml 634 638 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kim1">[27]</xref>
###xml 782 786 770 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Friedland1">[28]</xref>
###xml 829 844 817 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 900 904 888 892 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kahnert1">[29]</xref>
###xml 906 910 894 898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Mollenkopf1">[30]</xref>
###xml 933 937 921 925 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Ragno1">[31]</xref>
###xml 1001 1005 989 993 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Thuong1">[32]</xref>
###xml 1277 1290 1257 1270 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 155 163 <span type="species:ncbi:9606">patients</span>
###xml 329 336 <span type="species:ncbi:9606">patient</span>
###xml 602 610 <span type="species:ncbi:9606">patients</span>
###xml 679 687 <span type="species:ncbi:9606">patients</span>
###xml 696 704 <span type="species:ncbi:9606">patients</span>
###xml 829 844 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 887 893 <span type="species:ncbi:10090">murine</span>
###xml 964 972 <span type="species:ncbi:9606">patients</span>
It remains a challenge to try to identify molecular markers which may be indicative of tuberculosis infection in the host. Most TB studies have focused on patients with pulmonary tuberculosis (PTB). However, it has been shown that the magnitude and regulation of IFNgamma, CCL2 and CXCL9 may differ between the host responses of patient with PTB or extrapulmonary TB (ETB) [23]-[25]. In addition, within extrapulmonary TB, the relationship between IFNgamma and IL10 regulates the outcome of infection and affects the severity of disease [26]. TNFalpha gene expression has been shown to be increased in patients with extrapulmonary TB [27]. CXCL8 levels are raised in the sera of patients with TB patients and have been shown to be associated with unfavorable outcome of the disease [28]. Most work on transcriptional profiles of M. tuberculosis infected cells have been performed in the murine model [29], [30] or immortalized cells [31], with some recent work in patients with tuberculous meningitis [32]. As these cytokines and chemokines had previously been previously been shown to be differentially secreted according to disease site (pulmonary and extrapulmonary) and also disease severity, we chose to study CCL2, IFNgamma, IL10, CCL3, TNFalpha and CXCL8 in response to Mycobacterium infection of peripheral blood mononuclear cells (PBMCs).
###end p 15
###begin p 16
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-TheConsultantsConsortiumSoc1">[33]</xref>
###xml 161 164 161 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-World1">[1]</xref>
###xml 188 203 188 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 269 277 269 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 282 286 282 286 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan4">[34]</xref>
###xml 324 339 324 339 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 359 367 359 367 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 804 817 804 817 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 913 917 913 917 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain1">[35]</xref>
###xml 188 203 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 269 281 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 324 339 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 359 371 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 1022 1030 <span type="species:ncbi:9606">patients</span>
###xml 1120 1128 <span type="species:ncbi:9606">patients</span>
BCG vaccination coverage in the Pakistani population is approximately 70% [33] TB but transmission rates remain high with an incidence of 181/100,000 population [1]. Responses to virulent M. tuberculosis can differ from those of attenuated avirulent organisms such as, M. bovis BCG [34]. We have employed both live virulent M. tuberculosis and non-pathogenic M. bovis BCG in this study in order to assess whether it was possible to differentiate between immune responses to virulent and avirulent mycobacteria against a background of high transmission, in addition to environmental exposure to cross mycobacteria and wide BCG coverage. BCG vaccinated healthy controls (ECs) can be both tuberculin test positive (TST+) and negative (TST-). It has been shown recently that in clinically health individuals Mycobacterium-specific immune responses differ between those with tuberculin positive and negative reactions [35]. Therefore, we have separately described responses of TST+ and TST- ECs and compared them with those of patients with tuberculosis. We have investigated chemokine and cytokine responses in tuberculosis patients with differing clinical severity and sites including PTB and ETB, with a view to identifying markers of clinical disease severity.
###end p 16
###begin title 17
Materials and Methods
###end title 17
###begin title 18
Ethics Statement
###end title 18
###begin p 19
This work received approval from the Ethical Review Committee, The Aga Khan University, Karachi, Pakistan.
###end p 19
###begin title 20
Subject Selection
###end title 20
###begin p 21
###xml 92 96 92 96 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan5">[36]</xref>
###xml 1204 1208 1202 1206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Crofton1">[37]</xref>
###xml 1210 1214 1208 1212 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain2">[38]</xref>
###xml 3 11 <span type="species:ncbi:9606">patients</span>
###xml 98 106 <span type="species:ncbi:9606">Patients</span>
###xml 135 142 <span type="species:ncbi:9606">patient</span>
###xml 378 386 <span type="species:ncbi:9606">patients</span>
###xml 516 528 <span type="species:ncbi:9606">participants</span>
###xml 530 538 <span type="species:ncbi:9606">Patients</span>
###xml 733 736 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 761 769 <span type="species:ncbi:9606">patients</span>
###xml 800 803 <span type="species:ncbi:12721?0.9873544761140104">HIV</span>
###xml 814 822 <span type="species:ncbi:9606">Patients</span>
###xml 1077 1085 <span type="species:ncbi:9606">Patients</span>
###xml 1227 1235 <span type="species:ncbi:9606">patients</span>
TB patients in this study are a subset of a larger study and have been described previously [36]. Patients were recruited from the out-patient clinics of the Aga Khan University Hospital and Medical College (AKUH) and Masoomeen Hospital, Karachi. The subjects were all unrelated. All study subjects were examined, evaluated and recruited by infectious diseases consultants. The patients were newly diagnosed with </=7 days of anti-tuberculous therapy (ATT). All samples were taken with written informed consent from participants. Patients had no significant co-morbid conditions including diabetes mellitus, chronic renal failure, and chronic liver disease and were also not on any corticosteroid therapy. Although Pakistan is a low HIV prevalence setting, all patients were screened and found to be HIV negative. Patients with pulmonary TB (PTB, n = 34) were diagnosed by clinical examination, chest X-ray, sputum acid fast bacillus (AFB) Ziehl Neelsen straining, AFB culture and /or clinical response to treatment (as assessed by resolution of fever, cough and weight gain). Patients were diagnosed as having either minimal or moderately advanced disease based on the extent of lung tissue involvement [37], [38]. Of the PTB patients, 9 had minimal, while 25 had moderately advanced disease.
###end p 21
###begin p 22
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-WHO1">[39]</xref>
###xml 846 853 846 853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008459-t001">Table 1</xref>
###xml 0 8 <span type="species:ncbi:9606">Patients</span>
###xml 522 530 <span type="species:ncbi:9606">patients</span>
###xml 647 655 <span type="species:ncbi:9606">patients</span>
###xml 734 742 <span type="species:ncbi:9606">patients</span>
Patients with extrapulmonary TB (ETB) were stratified into disease severity groups according to the WHO ranking of clinical disease severity based on extent of disease and anatomical site and number of distal sites involved [39]. TB of the lymph nodes, unilateral pleural effusion, bone (excluding spine), peripheral join and skin was classified as less severe. TB of the meninges, pericardium, peritoneal cavity, bilateral or extensive pleural effusion, spine, intestines, or miliary TB was classified as severe. Sixteen patients were placed in the category of less severe localized ETB (L-ETB), comprising tuberculous lymphadenopathy. All L-ETB patients were confirmed on histological findings consistent with tuberculosis. Sixteen patients were classified as severe disseminated ETB (D-ETB). Diagnostic criteria used for D-ETB are provided in Table 1. Diagnosis of meningeal TB was based on CSF biochemical findings, supported by AFB culture and findings on contrast-enhanced CT scan and/or MRI. Pleural TB was diagnosed on the basis of pleural fluid biochemical findings, AFB culture, histopathological findings on pleural biopsy and supportive radiological evidence on X-rays and/or contrast-enhanced CT scan.
###end p 22
###begin title 23
###xml 24 32 <span type="species:ncbi:9606">patients</span>
Diagnostic criteria for patients with severe disseminated extrapulmonary tuberculosis (D-ETB).
###end title 23
###begin p 24
indicates acid fast bacilli staining of smears.
###end p 24
###begin p 25
includes Xray, MRI or CT imaging characteristic of tuberculosis.
###end p 25
###begin p 26
acid fast bacilli culture using BACTEC radiometric assay, Becton Dickinson, USA.
###end p 26
###begin p 27
###xml 87 102 87 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 87 102 <span type="species:ncbi:1773">M. tuberculosis</span>
biopsy results indicate caseating or necrotic granulomatous inflammation indicative of M. tuberculosis infection.
###end p 27
###begin p 28
showed a favorable clinical response to anti-tuberculous treatment.
###end p 28
###begin p 29
###xml 322 330 <span type="species:ncbi:9606">patients</span>
BCG-vaccinated asymptomatic healthy volunteers who were staff at AKU with no known exposure to TB were used as endemic controls (ECs). BCG vaccination was assessed based on the presence of a BCG scar. No member of the control group had a household member with tuberculosis nor did they have any relationship to any of the patients recruited in the study. All volunteers had a normal chest X-Ray. Tuberculin skin testing (TST) was assessed by intradermal administration of five tuberculin units on the volar surface of the right arm subcutaneously, and read by a single reader at 48 h. An induration of >/=10mm was used as a cutoff for positive responses. Both TST- (n = 19) and TST+ (n = 17) ECs were included in the study.
###end p 29
###begin title 30
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
Mycobacterium Culture
###end title 30
###begin p 31
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan6">[40]</xref>
###xml 90 98 90 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 821 825 815 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan6">[40]</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 90 102 <span type="species:ncbi:33892">M. bovis BCG</span>
M. tuberculosis (H37Rv) was acquired from ATCC and used as described previously [40]. The M. bovis BCG Montreal vaccine strain was used as the non-pathogenic strain. All strains were grown to logarithmic phase in 7H9 Middlebrook medium supplemented with 0.02% glycerol, 10% albumin dextrose catalase (ADC) Middlebrook enrichment and 0.5% Tween-80 (all from Difco Laboratories, Detroit, MI, USA). Aliquots of mycobacteria were frozen in growth medium containing 15% glycerol and stored at -70degreesC. For the infection assay, aliquots of mycobacteria were freshly thawed, washed three times in PBS and diluted as required for the infection. To avoid mycobacterial clumping, the cell suspension was sonicated briefly then allowed to stand for 5 min to allow large clumps to settle, leaving behind a single cell suspension [40]. A mycobacterial innoculum was also plated out for each assay to determine bacterial viability which was greater than 80% in each case.
###end p 31
###begin title 32
###xml 53 65 53 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacteria</italic>
Infection of Peripheral Blood Mononuclear Cells with Mycobacteria
###end title 32
###begin p 33
###xml 187 188 187 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 241 256 241 256 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 282 283 282 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 392 405 392 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 455 459 455 459 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan7">[41]</xref>
###xml 785 800 785 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 241 256 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 785 800 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 844 852 <span type="species:ncbi:9606">patients</span>
###xml 978 986 <span type="species:ncbi:9606">patients</span>
Peripheral blood mononuclear cells (PBMCs) were obtained by gradient separation of whole blood using Histopaque (GIBCO-BRL, USA). Cells were counted using a hemacytometer and plated at 106 per well in a 24 well tissue culture plate in 1 ml. M. tuberculosis and BCG inoculation of 106 CFU/ml (infection ratio of 1) was added to each well containing PBMCs. The time course and dose response to Mycobacterium infection of PBMCs has been described previously [41]. All supernatants were collected at 18 h post-stimulation for cytokine and chemokine measurements. Samples were centrifuged to collect any cellular debris, aliquoted and stored at -70 C until tested. Cell monolayers were harvested directly in Trizol reagent (Invitrogen, USA) for extraction of total RNA and stored at -70 C. M. tuberculosis-induced responses were tested in all 66 TB patients recruited in this study. However, 63/66 were used for BCG-stimulation experiments due to a lower yield of PBMCs from these 3 patients.
###end p 33
###begin title 34
ELISA for IFNgamma, IL-10, CCL2 and CCL3
###end title 34
###begin p 35
###xml 279 283 275 279 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan1">[23]</xref>
###xml 688 692 684 688 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan1">[23]</xref>
###xml 297 302 <span type="species:ncbi:9606">human</span>
###xml 706 711 <span type="species:ncbi:9606">human</span>
IFNgamma and IL-10 were detected in supernatants of stimulated PBMCs by using standards and ELISA reagents obtained from Endogen (Rockford, IL, USA). Cytokines were measured using a sandwich ELISA technique according to the manufacturer's instructions and as reported previously [23]. Recombinant human cytokine was used to obtain a dose response curve with a range of detection from 3.9-1000 pg/ml. All experimental samples were tested in duplicate. CCL2 and CCL3 standards and monoclonal antibody pairs for capture and detection were obtained from R&D Systems (Abingdon, UK). All measurements were carried out according to the manufacturer's recommendations and as described previously [23]. Recombinant human chemokine was used to obtain a dose response curve with a range of detection from 6.25-500 pg/ml for CCL3, and 6.25-1000 pg/ml for CCL2.
###end p 35
###begin title 36
Real Time Quantitative RT-PCR for Cytokine Gene Expression Quantification
###end title 36
###begin p 37
RNA was extracted from PBMC samples stored in Trizol reagent as per the manufacturer's instructions. RNA was heated at 70degreesC to denature and quantified using the NanoDrop ND1000 (NanoDrop Technologies, USA). Total RNA (1 microg) was reverse transcribed (RT) using MuLV reverse transcriptase (Invitrogen, USA) in a volume of 20 ul and cDNA was further diluted to 25 ul and used in PCR reactions.
###end p 37
###begin p 38
###xml 531 533 531 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">23</sup>
###xml 471 533 471 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Copies/ul &#8202;=&#8202; Xg/ul DNA &#247; (product size in bpx660)&#215;6.022&#215;10 <sup>23</sup></italic>
The absolute quantification method was used to determined gene expression in cells. Individual standards were prepared from gene specific PCR products generated using a conventional PCR machine, electrophoresed on an agarose gel and subsequently extracted and quantified. Quantification of cDNA product was carried out using a fluorescent quantification assay Quant-IT DNA Assay (Molecular Probes, USA). dsDNA concentration was calculated as copies/ul using the formula: Copies/ul  =  Xg/ul DNA / (product size in bpx660)x6.022x10 23.
###end p 38
###begin p 39
###xml 28 29 28 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 32 33 32 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
###xml 261 265 257 261 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Dheda1">[42]</xref>
###xml 288 308 284 304 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">CCCCAGTCACCTGCTGTTAT</named-content>
###xml 313 333 309 329 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">AGATCTCCTTGGCCACAATG</named-content>
###xml 348 368 344 364 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCTGCTTCAGCTACACCTC</named-content>
###xml 373 393 369 389 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TTTCTGGACCCACTCCTCAC</named-content>
###xml 432 451 428 447 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTCTGTGTGAAGGTGCAG</named-content>
###xml 456 476 452 472 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TCTGCACCCAGTTTTCCTTG</named-content>
###xml 495 515 487 507 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">TGCTTGTTCCTCAGCCTCTT</named-content>
###xml 520 541 512 533 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGTTTGCTACAACATGGCTAC</named-content>
###xml 782 800 774 792 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GCTTCCTGGAGGGTGTCC</named-content>
###xml 805 825 797 817 <named-content xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" content-type="gene">GGACTCGTTTGTACCCGTTG</named-content>
###xml 1303 1307 1295 1299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Dheda2">[43]</xref>
###xml 1674 1689 1666 1681 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 204 209 <span type="species:ncbi:9606">human</span>
###xml 1247 1252 <span type="species:ncbi:9606">human</span>
###xml 1503 1511 <span type="species:ncbi:9606">patients</span>
###xml 1585 1593 <span type="species:ncbi:9606">patients</span>
###xml 1674 1689 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1700 1707 <span type="species:ncbi:9606">patient</span>
Standard curves were used 106-101 copies/ well of each gene. For each sample, gene expression PCR was carried out using 2 microl of cDNA template with sequence specific primers. PCR was performed for the human acidic ribosomal protein (HuPO) house keeping gene [42]. Primers for CCL2 (F- CCCCAGTCACCTGCTGTTAT, R- AGATCTCCTTGGCCACAATG) and CCL3 (F- TGCTGCTTCAGCTACACCTC, R- TTTCTGGACCCACTCCTCAC) were from RT primer DB (). CXCL8 (F- GCTCTGTGTGAAGGTGCAG, R- TCTGCACCCAGTTTTCCTTG) and TNFalpha (F- TGCTTGTTCCTCAGCCTCTT, R- GGTTTGCTACAACATGGCTAC) sequences were by courtesy of Martin Holland, LSHTM, UK. All assays employed incorporation of the SYBR Green dye (BIORAD laboratories, USA). Cytokine gene expression ratios were calculated in each case after normalization against HuPO (F- GCTTCCTGGAGGGTGTCC, R- GGACTCGTTTGTACCCGTTG). Typical assay conditions employed were: initial denaturation 50 C, 2 min; 95 C, 15 min; 40 cycles 95C, 15s, 60 C,60 s. This was followed by a melting curve dissociation analysis to check specificity of PCR products. All experiments were carried out using an iCycler real-time PCR machine, BIORAD Laboratories, USA. Data are depicted as fold increase in each target gene per 100 copies. All genes were normalized to the human acidic ribosomal protein (HuP0) housekeeping gene [43]. Fold increase in gene expression were determined based on results of stimulated cells as a fold change in gene expression as compared with basal levels in unstimulated cells. Of the total 66 TB patients recruited in this study, gene expression studies were performed on 50 TB patients. Of these, PBMC gene expression data was available on 50 donors stimulated with M. tuberculosis and 44 TB patient PBMCs stimulated with BCG.
###end p 39
###begin title 40
Statistical Analysis
###end title 40
###begin p 41
All data were analyzed using the Statistical Package for Social Sciences software (SPSS). Analysis of non-parametric data was performed using the Mann-Whitney U test and the Kruskal-Wallis test as was appropriate. P values</=0.05 were considered to indicate significant differences between groups.
###end p 41
###begin title 42
Results
###end title 42
###begin p 43
###xml 97 104 97 104 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008459-t002">Table 2</xref>
###xml 290 294 290 294 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-TheConsultantsConsortiumSoc1">[33]</xref>
###xml 573 588 573 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 793 808 793 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
###xml 573 588 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 793 808 <span type="species:ncbi:1773">M. tuberculosis</span>
The hematological characteristics of patients and controls included in the study are provided in Table 2, with each group shown separately. While BCG vaccination is administered at birth as part of the National Expanded Immunization Program in the country its coverage is at best up to 70% [33]. Therefore, we also documented the presence of a BCG scar in subjects to determine whether they had a history of BCG vaccination. TB transmission rates in the country are high with an incidence of 181/100,000 therefore only the TST- EC group can be considered as un-infected by M. tuberculosis. The TST+ EC group is also clinically healthy but it not possible to assess whether their positive tuberculin reaction is attributable to BCG vaccination or exposure to environmental mycobacteria or even M. tuberculosis. Hence we have considered TST+ and TST- ECs separately.
###end p 43
###begin title 44
###xml 32 40 <span type="species:ncbi:9606">patients</span>
Characteristics of tuberculosis patients and controls in the study.
###end title 44
###begin p 45
TST, tuberculin skin test; TST+ individuals had an induration >/=10 mm in size.
###end p 45
###begin p 46
PTB, pulmonary TB; localized extrapulmonary TB, L-ETB; disseminated ETB, D-ETB.
###end p 46
###begin p 47
IQR, interquartile range between 25th and 75th percentile.
###end p 47
###begin p 48
'#' based on presence of BCG scar.
###end p 48
###begin p 49
'*' denotes p<0.05 using the Kruskal-Wallis nonparametric test, values in bold indicate those which are significantly higher.
###end p 49
###begin p 50
###xml 75 83 <span type="species:ncbi:9606">patients</span>
###xml 127 135 <span type="species:ncbi:9606">Patients</span>
###xml 201 209 <span type="species:ncbi:9606">patients</span>
###xml 370 377 <span type="species:ncbi:9606">patient</span>
###xml 399 407 <span type="species:ncbi:9606">Patients</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
We found that there was a significant difference between the age groups of patients with TB and healthy controls, (p = 0.034). Patients with both localized ETB and disseminated ETB were older than PTB patients (p = 0.011, p = 0.042, respectively, using Mann-Whitney U nonparametric analysis). As indicated, there was a significant difference between BCG vaccinees in TB patient groups, (p = 0.029). Patients with L-ETB had greater numbers of BCG vaccinees than those with either PTB or D-ETB. There was no relationship between the age of patients and their BCG scar status.
###end p 50
###begin p 51
###xml 167 171 167 171 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain3">[44]</xref>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
Data indicated an increase in lymphocyte, monocyte and neutrophil counts in TB patients when compared with endemic controls, and is in agreement with previous studies [44].
###end p 51
###begin title 52
###xml 10 25 10 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 10 25 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 63 71 <span type="species:ncbi:9606">Patients</span>
Increased M. tuberculosis - and BCG- Induced CCL2 Secretion in Patients with TB
###end title 52
###begin p 53
###xml 53 61 53 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 148 163 148 163 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 167 175 167 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 235 247 235 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacteria</italic>
###xml 269 285 269 285 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis-</italic>
###xml 290 298 290 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 474 481 474 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008459-t003">Table 3</xref>
###xml 581 596 581 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 730 745 730 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 846 861 846 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 53 65 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 148 163 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 167 179 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 269 284 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 290 302 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 434 442 <span type="species:ncbi:9606">patients</span>
###xml 556 564 <span type="species:ncbi:9606">patients</span>
###xml 581 596 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 652 660 <span type="species:ncbi:9606">patients</span>
###xml 730 745 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 822 830 <span type="species:ncbi:9606">patients</span>
###xml 846 861 <span type="species:ncbi:1773">M. tuberculosis</span>
It is important to understand the difference between M. bovis BCG vaccination induced immunity and that elicited in response to challenge by either M. tuberculosis or M. bovis BCG. In order to establish the specificity of responses to Mycobacteria, we first determined M. tuberculosis- and M. bovis BCG- induced chemokine and cytokine responses in healthy endemic controls (ECs; TST- (N = 19), TST+ (N = 17) as compared with those of patients with tuberculosis. As shown in Table 3, spontaneous secretion of CCL2 from unstimulated PBMCs of controls and TB patients was comparable. M. tuberculosis -induced CCL2 was significantly greater in PBMCs of TB patients as compared with both TST- and TST+ ECs (p<0.001). CCL2 responses to M. tuberculosis and BCG showed a parallel trend although the magnitude of secretion from TB patients in response to M. tuberculosis was significantly greater as compared with BCG (p<0.001).
###end p 53
###begin title 54
###xml 10 25 10 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 31 39 31 39 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 10 25 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 31 43 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 107 115 <span type="species:ncbi:9606">patients</span>
Increased M. tuberculosis- and M. bovis BCG - induced CCL2 and IL10 and decreased IFNgamma responses in TB patients.
###end title 54
###begin p 55
###xml 62 70 <span type="species:ncbi:9606">patients</span>
ECs, healthy endemic controls; TST, tuberculin skin test; TB, patients with tuberculosis.
###end p 55
###begin p 56
'delta' denotes cytokine secretion after background subtraction in each case.
###end p 56
###begin p 57
'*' denotes p<0.05 using the Kruskal-Wallis nonparametric test; values in bold indicate those which are significantly higher.
###end p 57
###begin p 58
###xml 35 37 35 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
###xml 44 46 44 46 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">th</sup>
IQR, interquartile range between 25th and 75th percentile.
###end p 58
###begin title 59
###xml 10 25 10 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 10 25 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 86 94 <span type="species:ncbi:9606">Patients</span>
Decreased M. tuberculosis - and BCG- Induced IFNgamma and Increased IL10 Secretion in Patients with TB
###end title 59
###begin p 60
###xml 83 98 79 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 149 164 145 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 266 273 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008459-t003">Table 3</xref>
###xml 276 291 268 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 517 532 505 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 83 98 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 149 164 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
###xml 276 291 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 401 409 <span type="species:ncbi:9606">patients</span>
###xml 517 532 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 568 576 <span type="species:ncbi:9606">patients</span>
IFNgamma in coordination with IL10 plays a key role in protective immunity against M. tuberculosis by regulating effector responses in tuberculosis. M. tuberculosis-induced IFNgamma levels were significantly lower in TB patients (p = 0.042, Kruskal Wallis analysis; Table 3). M. tuberculosis-induced IFNgamma did not differ significantly between the TST stratified EC groups. However, responses of TB patients were significantly lower than TST+ ECs (p = 0.022, Mann-Whitney U test), and although there was trend that M. tuberculosis-induced IFNgamma was also lower in patients than TST- ECs, this did not reach significance.
###end p 60
###begin p 61
###xml 301 316 293 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 61 69 <span type="species:ncbi:9606">patients</span>
###xml 129 137 <span type="species:ncbi:9606">patients</span>
###xml 301 316 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 371 379 <span type="species:ncbi:9606">patients</span>
BCG-induced IFNgamma secretion was significantly lower in TB patients as compared with ECs (p<0.01, Kruskal Wallis analysis). TB patients showed lower IFNgamma responses compared to both TST- and TST+ ECs (p<0.001, p<0.001, respectively, Mann Whitney U test). This suggests that although the trend of M. tuberculosis- and BCG-induced IFNgamma secretion was similar in TB patients, the responses differed in TST+ and TST- ECs control groups indicating that the immune responses measured here were specific to the mycobacterial stimulus. Also, increased IFNgamma responses in the TST+ EC group may reflect previous exposure leading to increased IFNgamma responses due to activation of effector T memory cells in this group.
###end p 61
###begin p 62
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 68 76 <span type="species:ncbi:9606">patients</span>
###xml 200 208 <span type="species:ncbi:9606">patients</span>
M. tuberculosis-induced IL10 levels were significantly raised in TB patients as compared with both TST- and TST+ ECs (p<0.001, Kruskal Wallis test). Similarly, BCG-induced IL10 was also greater in TB patients as compared with both TST- and TST+ ECs (p<0.001, Kruskal Wallis test).
###end p 62
###begin title 63
###xml 0 26 0 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 0 26 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 64 72 <span type="species:ncbi:9606">Patients</span>
Mycobacterium tuberculosis - and BCG- Induced CCL3 Secretion in Patients with TB
###end title 63
###begin p 64
###xml 41 55 41 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M tuberculosis</italic>
###xml 78 82 78 82 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Saukkonen2">[45]</xref>
###xml 123 138 123 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 160 164 160 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Volpe1">[46]</xref>
###xml 180 194 180 194 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium-</italic>
###xml 250 265 250 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 346 353 346 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0008459-t003">Table 3</xref>
###xml 123 138 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 250 265 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 315 323 <span type="species:ncbi:9606">patients</span>
CCL3 has been shown to be inhibitory for M tuberculosis growth in macrophages [45] and has been shown to be upregulated in M. tuberculosis infected macrophages [46]. We determined Mycobacterium- induced CCL3 secretion in PBMCs and found that neither M. tuberculosis- nor BCG-induced levels of CCL3 differed between patients and healthy controls (Table 3).
###end p 64
###begin title 65
###xml 49 64 45 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 49 64 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 68 76 <span type="species:ncbi:9606">Patients</span>
Reduced CCL2 but Increased IFNgamma Secretion to M. tuberculosis in Patients with Localized ETB Compared to PTB
###end title 65
###begin p 66
###xml 33 46 33 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 119 123 119 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan1">[23]</xref>
###xml 125 129 125 129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan3">[25]</xref>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Crofton1">[37]</xref>
###xml 632 636 632 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-World2">[47]</xref>
###xml 225 233 <span type="species:ncbi:9606">patients</span>
###xml 289 297 <span type="species:ncbi:9606">patients</span>
###xml 359 367 <span type="species:ncbi:9606">Patients</span>
###xml 559 567 <span type="species:ncbi:9606">patients</span>
Previous studies have shown that Mycobacterium induced host immune responses differ in pulmonary and extrapulmonary TB [23], [25]. We investigated the association between chemokine and cytokine activation in the tuberculosis patients and the clinical severity of their disease by studying patients with either pulmonary (PTB) or extrapulmonary disease (ETB). Patients were further stratified into either minimal (min-PTB) or moderately advanced (mod-PTB) disease in the pulmonary group on the basis of lung tissue involvement [37] Extrapulmonary tuberculosis patients were stratified accordingly to WHO clinical severity guidelines [47] into less severe localized disease (L-ETB) or severe disseminated disease (D-ETB).
###end p 66
###begin p 67
###xml 44 59 44 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 361 370 361 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Figure 1A</xref>
###xml 372 387 372 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 44 59 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 97 105 <span type="species:ncbi:9606">patients</span>
###xml 262 270 <span type="species:ncbi:9606">patients</span>
###xml 280 287 <span type="species:ncbi:9606">patient</span>
###xml 372 387 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 431 439 <span type="species:ncbi:9606">patients</span>
###xml 530 538 <span type="species:ncbi:9606">patients</span>
We found no significant differences between M. tuberculosis-induced CCL2 responses from PBMCs of patients with minimal or moderately advanced PTB (median; min-PTB, 31.5; mod-PTB, 1712 pg/ml, p = 0.16), although the trend of CCL2 secretion was greater in mod-PTB patients. The PTB patient groups were combined for comparison with those of ETB group. As shown in Figure 1A, M. tuberculosis -induced CCL2 was significantly greater in patients with PTB as compared with L-ETB (p = 0.001). In addition, CCL2 secreted levels from L-ETB patients were also reduced as compared with those with D-ETB (p<0.001).
###end p 67
###begin title 68
###xml 13 28 13 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 13 28 <span type="species:ncbi:1773">M. tuberculosis</span>
Differential M. tuberculosis- and BCG- induced CCL2 and IFNgamma responses with TB clinical disease severity.
###end title 68
###begin p 69
###xml 9 10 9 10 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 31 46 31 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 57 58 57 58 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 507 522 507 522 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 728 743 728 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 31 46 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 507 522 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 560 568 <span type="species:ncbi:9606">patients</span>
###xml 728 743 <span type="species:ncbi:1773">M. tuberculosis</span>
PBMCs (106) were infected with M. tuberculosis or BCG (106 CFU) for 18 h after which cell supernatants were harvested for the measurement of cytokines and chemokines. The box plots represent the data for each group after the level of cytokine secretion from unstimulated cells was subtracted. The whiskers indicate the 25th and 75th quartiles, while a line indicating the median separates the two. '*', denotes significant differences between groups (p<0.05) using the Mann-Whitney U test. The data show A) M. tuberculosis-induced CCL2 responses of PBMCs from patients with pulmonary tuberculosis (PTB, n = 34) and extrapulmonary TB with less severe localized (L-ETB, n = 16) and severe disseminated (D-ETB, n = 16) disease, B) M. tuberculosis-induced IFNgamma responses BCG-induced CCL2 responses (C) and IFNgamma responses (D) were obtained from PTB, n = 33; L-ETB, n = 16; D-ETB, n = 14.
###end p 69
###begin p 70
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 170 185 166 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 330 337 322 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Fig. 1B</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 80 88 <span type="species:ncbi:9606">patients</span>
###xml 170 185 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 243 251 <span type="species:ncbi:9606">patients</span>
###xml 511 518 <span type="species:ncbi:9606">patient</span>
M. tuberculosis-induced IFNgamma responses did not differ significantly between patients with min-PTB and mod-PTB (median: minPTB, 298.1; mod-PTB, 233 pg/ml, p = 0.841). M. tuberculosis- induced IFNgamma secretion in the combined group of PTB patients was significantly lower than responses observed in the L-ETB group (p = 0.04, Fig. 1B). Surprisingly, no difference was observed between IFNgamma levels from D-ETB and L-ETB which may be due to the variability in IFNgamma responses between donors within each patient group.
###end p 70
###begin title 71
###xml 62 70 <span type="species:ncbi:9606">Patients</span>
BCG-Induces Reduced CCL2 and IFNgamma Secretion from PBMCs of Patients with D-ETB
###end title 71
###begin p 72
###xml 65 71 65 71 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Fig. 1</xref>
###xml 377 384 377 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Fig. 1C</xref>
###xml 502 509 502 509 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Fig. 1C</xref>
###xml 93 101 <span type="species:ncbi:9606">patients</span>
###xml 284 292 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 414 422 <span type="species:ncbi:9606">patients</span>
We also determined BCG-induced chemokine and cytokine responses (Fig. 1 C and D) in PBMCs of patients with pulmonary and extrapulmonary TB, in order to investigate a relationship between cytokine induction and disease severity in the groups. Overall, BCG-induced CCL2 levels from PTB patients were significantly raised as compared with those from patients with L-ETB (p<0.001, Fig. 1C). BCG-induced CCL2 levels of patients with D-ETB were also greater than those observed in the L-ETB group (p<0.001), Fig. 1C.
###end p 72
###begin p 73
###xml 143 150 139 146 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g001">Fig. 1D</xref>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 110 118 <span type="species:ncbi:9606">patients</span>
###xml 163 171 <span type="species:ncbi:9606">patients</span>
BCG-induced IFNgamma from PBMCs of L-ETB patients on the other hand was significantly greater than those from patients with D-ETB (p = 0.036), Fig. 1D. Within PTB patients, BCG-induced CCL2 did not differ significantly between minimal and moderate disease (median: min-PTB, 0; mod-PTB, 167.4 pg/ml; p = 0.189) and BCG-induced IFNgamma also showed the same trend (median: min-PTB, 673; mod-PTB, 597 pg/ml; p = 0.906).
###end p 73
###begin title 74
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis - and BCG-Induced IL10 and CCL3 Responses Do Not Differ between PTB and ETB Severity Groups
###end title 74
###begin p 75
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 80 90 80 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s001">Figure S1A</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 228 236 <span type="species:ncbi:9606">patients</span>
M. tuberculosis-induced IL10 levels were comparable between PTB and ETB groups (Figure S1A) but there was an increasing trend of IL10 in the disseminated ETB group (median: PTB, 56; L-ETB, 134; D-ETB, 282 pg/ml). Within the PTB patients a higher trend in IL10 was noted in mod-PTB as compared with min-PTB group (median: min-PTB, 22.6 pg/ml; mod-PTB, 483 pg/ml, p = 0.078), however this difference was not significant.
###end p 75
###begin p 76
###xml 0 16 0 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis-</italic>
###xml 135 143 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s001">Fig. S1B</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 117 125 <span type="species:ncbi:9606">patients</span>
###xml 232 240 <span type="species:ncbi:9606">patients</span>
M. tuberculosis- induced CCL3 concentrations were found to be comparable between the pulmonary and extrapulmonary TB patients studied (Fig. S1B: median; PTB, 1306; L-ETB, 999 D-ETB, 1471 pg/ml, respectively), as well as between PTB patients with either minimal or moderate disease (median; min-PTB, 974; mod-PTB, 1425; p = 0.653).
###end p 76
###begin p 77
###xml 69 77 69 77 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s001">Fig. S1C</xref>
###xml 530 534 530 534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-OGarra1">[48]</xref>
BCG-induced IL10 levels were comparable between PTB and E-TB groups (Fig. S1C) although there was an increasing trend of IL10 in the disseminated ETB group (median: PTB, 36; L-ETB, 69; D-ETB, 93 pg/ml). Although not significant, again BCG-induced IL10 responses of PBMCs showed a higher trend in mod-PTB as compared with min-PTB group (median: min-PTB, 35.9 pg/ml; mod-PTB, 311 pg/ml, p = 0.228). Association of IL10 with increasing pathology supports the hypothesis that IL10 may play a role in reducing collateral tissue damage [48].
###end p 77
###begin p 78
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">-</italic>
###xml 259 267 259 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s001">Fig. S1D</xref>
###xml 41 49 <span type="species:ncbi:9606">patients</span>
###xml 241 249 <span type="species:ncbi:9606">patients</span>
BCG- induced CCL3 was comparable between patients with either minimal or moderate PTB (median; min-PTB, 974; mod-PTB, 1425; p = 0.834). BCG- induced CCL3 concentrations were found to be comparable between the pulmonary and extrapulmonary TB patients studied (Fig. S1D; median: PTB, 1592; L-ETB, 1056; D-ETB, 1296 pg/ml, respectively), indicating an absence of association of CCL3 with TB disease severity.
###end p 78
###begin title 79
Differential CCL2 and TNFalpha Gene Expression in Pulmonary and Extrapulmonary Tuberculosis
###end title 79
###begin p 80
###xml 60 75 60 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 262 277 262 277 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 452 456 448 452 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Algood2">[49]</xref>
###xml 458 462 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Chaly1">[50]</xref>
###xml 673 677 665 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Friedland2">[51]</xref>
###xml 757 772 749 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 868 875 860 867 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g002">Fig. 2A</xref>
###xml 922 937 914 929 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1035 1050 1027 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1111 1118 1099 1106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g002">Fig. 2B</xref>
###xml 60 75 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 79 87 <span type="species:ncbi:9606">patients</span>
###xml 262 277 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 757 772 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 858 866 <span type="species:ncbi:9606">patients</span>
###xml 922 937 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 990 998 <span type="species:ncbi:9606">patients</span>
###xml 1035 1050 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 1101 1109 <span type="species:ncbi:9606">patients</span>
Many reports which have investigated chemokine responses to M. tuberculosis in patients have focused on either protein secretion or gene expression responses. To determine whether the secretory patterns we observed matched gene expression trends we investigated M. tuberculosis -induced mRNA transcripts in stimulated PBMCs by studying CCL2 and CCL3 expression. As CCL2 and CCL3 expression is regulated by TNFalpha, a critical activator of macrophages [49], [50] we also determined the expression of TNFalpha. In addition, we investigated the expression of CXCL8, which is responsible for neutrophil recruitment and has been shown to play a role in tuberculosis infections [51]. We determined gene expression in both pulmonary and extrapulmonary TB groups. M. tuberculosis infection of PBMCs resulted in significantly greater CCL2 expression in PBMCs of PTB patients (Fig. 2A) as compared to those with L-ETB (p = 0.023). M. tuberculosis induced CCL2 expression was also increased in D-ETB patients as compared with L-ETB (p = 0.005). M. tuberculosis-induced TNFalpha was significantly greater in PTB patients (Fig. 2B) as compared with L-ETB (p = 0.02). TNFalpha expression was also raised in D-ETB as compared with L-ETB (p = 0.09), although this difference was not significant.
###end p 80
###begin title 81
###xml 13 28 13 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 13 28 <span type="species:ncbi:1773">M. tuberculosis</span>
Differential M. tuberculosis-induced CCL2 and TNFalpha mRNA expression in pulmonary and extrapulmonary TB.
###end title 81
###begin p 82
###xml 23 36 23 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 493 508 493 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 493 508 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 617 625 <span type="species:ncbi:9606">patients</span>
###xml 737 745 <span type="species:ncbi:9606">patients</span>
RNA was extracted from Mycobacterium-infected PBMCs after 18 h post stimulation and subjected to RTPCR for chemokine and cytokine genes. Box plots depict fold increase in gene expression after normalization to the housekeeping gene HuPO. The whiskers indicate the 25th and 75th quartiles, while a line indicating the median separates the two. '*', p<0.05, indicate differences between groups using the Mann-Whitney U test. Data is depicted as fold increase in each target gene per 100 copies. M. tuberculosis -induced mRNA expression of A) CCL2, and B) TNFalpha is shown for PTB, n = 22; L-ETB, n = 15, D-ETB, n = 13 patients. BCG-induced mRNA expression of C) CCL2 and D) TNFalpha is shown for PTB, n = 16; L-ETB, n = 14; L-ETB, n = 14 patients. '*', p<0.05, indicate differences between groups using the Mann-Whitney U test, TNFa (TNFalpha).
###end p 82
###begin p 83
###xml 83 98 83 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 184 191 184 191 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g002">Fig. 2A</xref>
###xml 282 289 278 285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="pone-0008459-g002">Fig. 2B</xref>
###xml 83 98 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
BCG-induced CCL2 mRNA expression was lower in PTB as compared with that induced by M. tuberculosis. No difference was found between BCG-induced CCL2 mRNA expression between TB groups (Fig. 2A). BCG-induced TNFalpha was greater in patients with PTB than those with L-ETB (p = 0.03), Fig. 2B.
###end p 83
###begin p 84
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 110 123 110 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s002">Figure S2 A-B</xref>
###xml 143 151 143 151 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s002">Fig. S2C</xref>
###xml 182 190 182 190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0008459.s002">Fig. S2D</xref>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
M. tuberculosis- induced CCL3 and CXCL8 mRNA transcripts were comparable between PTB, L-ETB and D-ETB groups, Figure S2 A-B. BCG-induced CCL3 (Fig. S2C) and, -CXCL8 mRNA expression (Fig. S2D) were also comparable between TB groups.
###end p 84
###begin title 85
Discussion
###end title 85
###begin p 86
Our data illustrates differences in the activation of immune regulatory chemokines and cytokines in tuberculosis disease with differing site and severity. CCL2 has potent chemotactic and activating properties for monocytes, macrophages, dendritic cells and CD4+ T cells. The most significant finding was that CCL2 was consistently associated with severe disease. We propose that CCL2 could be a useful adjunct marker of severity in tuberculosis.
###end p 86
###begin p 87
###xml 133 148 133 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 188 196 188 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 221 236 221 236 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 257 265 257 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. bovis</italic>
###xml 292 307 292 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 133 148 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 221 242 <span type="species:ncbi:83332">M. tuberculosis H37Rv</span>
###xml 257 269 <span type="species:ncbi:33892">M. bovis BCG</span>
###xml 292 307 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 351 359 <span type="species:ncbi:9606">patients</span>
To evaluate differences between background immune responses due to BCG vaccination and environmental mycobacteria and infection with M. tuberculosis, we investigated host immune responses in vitro infection with virulent M. tuberculosis H37Rv and avirulent M. bovis BCG vaccine strains. Both M. tuberculosis and BCG elicited an increase in CCL2 in TB patients as compared with controls. CCL2 is responsible for the recruitment of leucocytes to the site of infection and therefore raised CCL2 may be characteristic of granuloma formation and the influx of monocyte driven responses.
###end p 87
###begin p 88
###xml 17 32 17 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 162 166 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan8">[52]</xref>
###xml 356 360 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan9">[53]</xref>
###xml 728 732 716 720 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain4">[54]</xref>
###xml 17 32 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 84 92 <span type="species:ncbi:9606">patients</span>
###xml 230 238 <span type="species:ncbi:9606">patients</span>
###xml 347 355 <span type="species:ncbi:9606">patients</span>
###xml 577 585 <span type="species:ncbi:9606">patients</span>
###xml 620 628 <span type="species:ncbi:9606">patients</span>
###xml 719 727 <span type="species:ncbi:9606">patients</span>
Our finding that M. tuberculosis infection results in reduced IFNgamma secretion in patients as compared with TST+ ECs donors is consistent with previous reports [52]. The BCG-induced IFNgamma responses which were depressed in TB patients compared with both TST- ECS and TST+ ECS healthy controls also confirm our previous reports on pulmonary TB patients [53]. All of our ECs were BCG vaccinated so the increased IFNgamma responses to BCG may be related to the presence of T memory recall responses in these individuals. The absence of similar T memory recall responses in TB patients could be due to raised IL10 in TB patients as compared with healthy controls, resulting in down modulation of T cell responses in TB patients [54].
###end p 88
###begin p 89
###xml 57 72 57 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 97 101 97 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Dorner2">[55]</xref>
###xml 103 107 103 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Saukkonen3">[56]</xref>
###xml 118 133 118 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 350 365 350 365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 57 72 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 118 133 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 305 313 <span type="species:ncbi:9606">patients</span>
###xml 350 365 <span type="species:ncbi:1773">M. tuberculosis</span>
CCL3 is a macrophage and T cell attractant, activated by M. tuberculosis infection of host cells [55], [56]. We found M. tuberculosis and BCG both induced CCL3 secretion and gene expression in PBMCs. However, we found no association of CCL3 (either protein levels or gene expression) between tuberculosis patients and healthy controls in response to M. tuberculosis or BCG stimulation.
###end p 89
###begin p 90
###xml 86 99 86 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium</italic>
###xml 193 197 193 197 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kahnert2">[57]</xref>
###xml 199 203 199 203 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Mollenkopf2">[58]</xref>
###xml 222 224 222 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et</italic>
###xml 236 251 236 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Ragno2">[59]</xref>
###xml 180 186 <span type="species:ncbi:10090">murine</span>
###xml 236 251 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 538 546 <span type="species:ncbi:9606">patients</span>
While a number of studies have utilized both microarray and RT-PCR studies to analyze Mycobacterium-induced expression in macrophages, most of these studies have been performed in murine cells [57], [58]. A study by Ragno et al. showed M. tuberculosis induced changes in the THP-1 monocytic cell line, where it was reported that a number of chemokines such as CCL2, CCL3, CXCL8 in addition to cell surface adhesion molecules ICAM and integrins were upregulated post-infection [59]. There is limited data on gene expression profiles in TB patients with differing severity of disease.
###end p 90
###begin p 91
###xml 234 238 234 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Fine1">[60]</xref>
###xml 254 262 <span type="species:ncbi:9606">patients</span>
###xml 294 301 <span type="species:ncbi:9606">patient</span>
While the value of BCG vaccination in early childhood to prevent disseminated disease is widely accepted the value of BCG vaccination in adult population particularly for pulmonary disease has been challenged in high burden countries [60]. The number of patients who were BCG vaccinated in the patient groups varied; with a greater proportion in L-ETB (82%) than those with D-ETB (40%). There is very limited data on the protection provided by BCG in adult tuberculosis and although this data is too small to draw any conclusions it suggests that BCG vaccination may result in a preponderance of less severe extrapulmonary TB disease.
###end p 91
###begin p 92
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Forssbohm1">[61]</xref>
###xml 211 215 211 215 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Ebdrup1">[63]</xref>
###xml 309 312 309 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Cagatay1">[2]</xref>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
###xml 197 205 <span type="species:ncbi:9606">patients</span>
###xml 230 236 <span type="species:ncbi:9103">Turkey</span>
###xml 300 308 <span type="species:ncbi:9606">patients</span>
###xml 321 329 <span type="species:ncbi:9606">patients</span>
###xml 390 398 <span type="species:ncbi:9606">patients</span>
###xml 502 510 <span type="species:ncbi:9606">patients</span>
The data available regarding age of ETB patients is variable according to region and ethnicity of the study populations, with ETB associated with younger age (<25) and females in African and Asian patients [61]-[63]. Reports from Turkey show that the predominant age range studies is 25-44 y for ETB patients [2]. Our TB patients were of the range 24.5-31.5 y, and within this we found ETB patients to be older than those with PTB (p = 0.034). This may also not be a contradictory result as all of our patients were already in a younger age range. A larger number of samples with a broader age range need to be analyzed for further confirmation.
###end p 92
###begin p 93
###xml 84 99 84 99 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 256 272 256 272 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis-</italic>
###xml 430 445 430 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 980 984 980 984 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan1">[23]</xref>
###xml 986 990 986 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Sterling1">[64]</xref>
###xml 23 31 <span type="species:ncbi:9606">patients</span>
###xml 84 99 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 160 168 <span type="species:ncbi:9606">patients</span>
###xml 256 271 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 402 410 <span type="species:ncbi:9606">patients</span>
###xml 430 445 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 475 483 <span type="species:ncbi:9606">patients</span>
###xml 694 702 <span type="species:ncbi:9606">patients</span>
###xml 948 956 <span type="species:ncbi:9606">patients</span>
When responses between patients with pulmonary and extrapulmonary TB were compared, M. tuberculosis and BCG-induced CCL2 secretion was found to be increased in patients with pulmonary TB as compared with those with less severe localized extrapulmonary TB. M. tuberculosis- induced secretion and mRNA expression of CCL2 was greater in PTB than in L-ETB, and also reduced in L-ETB as compared with D-ETB patients. Our comparison of M. tuberculosis and BCG-induced responses in patients illustrated that although the trend of response to the mycobacteria was similar, the magnitude of responses to the virulent mycobacteria was greater than that to attenuated BCG. As the L-ETB group consisted of patients with tuberculous lymphadenopathy, this may indicate more active monocyte and T cell recruitment in disease localized to the lung parenchyma as compared to lymph nodes. It also supports previous reports of increased CCL2 secretion in cells of TB patients with pulmonary disease [23], [64].
###end p 93
###begin p 94
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Mastroianni1">[65]</xref>
###xml 476 480 476 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Thwaites1">[67]</xref>
###xml 29 37 <span type="species:ncbi:9606">patients</span>
###xml 341 349 <span type="species:ncbi:9606">patients</span>
The raised CCL2 responses in patients with severe disseminated D-ETB (spinal, tuberculous meningitis and abdominal TB) as compared with L-ETB, also indicate that increased CCL2 is associated with increasing disease severity. This fits with previous work which has shown that levels of inflammatory chemokines are increased in body fluids of patients with extrapulmonary disseminated infections TB such as in tuberculous meningitis, spinal tuberculosis or miliary disease [65]-[67].
###end p 94
###begin p 95
###xml 7 22 7 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 180 184 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hasan3">[25]</xref>
###xml 611 626 595 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 688 692 672 676 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain5">[68]</xref>
###xml 701 705 685 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Jamil2">[69]</xref>
###xml 872 887 852 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 1058 1062 1034 1038 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Flynn2">[70]</xref>
###xml 7 22 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 611 626 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 872 887 <span type="species:ncbi:1773">M. tuberculosis</span>
Raised M. tuberculosis - induced IFNgamma in localized L-ETB as compared with pulmonary TB corresponds with previous studies employing mycobacterial antigen ESAT6 driven responses [25]. The WHO clinical classification of tuberculosis disease severity lists tuberculous lymphadenitis as the least severe form of TB. The increased effector T cell IFNgamma response in the L-ETB group as compared with pulmonary TB may reflect a reduction in IFNgamma with increasing mycobacterial load, inflammation and clinical severity. We have also previously reported an inverse relationship of IFNgamma levels in response to M. tuberculosis culture filtrate proteins with clinical severity in both PTB [68] and ETB [69]. BCG-induced IFNgamma was raised in L-ETB but only when compared with the D-ETB group. As there were more BCG vaccinees in the L-ETB group this may reflect increased M. tuberculosis-specific T cell responses than in the D-ETB group. This is consistent with the role of IFNgamma as a potent activator of macrophages for mycobacterial killing and stasis [70].
###end p 95
###begin p 96
###xml 37 52 37 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 211 213 211 213 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et</italic>
###xml 359 363 359 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Qiu1">[71]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Qiu2">[72]</xref>
###xml 577 592 577 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 690 694 690 694 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Friedland3">[73]</xref>
###xml 37 52 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 109 117 <span type="species:ncbi:9606">patients</span>
###xml 577 592 <span type="species:ncbi:1773">M. tuberculosis</span>
We did not observe any difference in M. tuberculosis induced CCL3 secretion, or CCL3 mRNA expression between patients with pulmonary or extrapulmonary TB with disease in single or multiple sites. Reports by Qiu et al. have shown CCL3, CXCL10 and their receptors CCR3, CCR4 and CXCR3 to be upregulated in an unbalanced manner in severe TB in the macaque model [71]. However, in the same study they observed low antigen specific cellular responses in the severely infected macaques [72], indicating a reduced ability of the immune cells to respond to a subsequent challenge with M. tuberculosis. Previously, increasing levels of CXCL8 have been shown to be associated with fatal tuberculosis [73]. Therefore, the lack of difference in CXCL8 transcription observed in localized and severe ETB may be due to an antigen specific anergy in severe disease.
###end p 96
###begin p 97
###xml 152 156 148 152 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Keane1">[74]</xref>
###xml 223 238 215 230 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 328 330 320 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">et</italic>
###xml 335 339 327 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Kahnert3">[75]</xref>
###xml 223 238 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 278 284 <span type="species:ncbi:10090">murine</span>
TNFalpha has previously been associated with increasing bacterial load and to be responsible for disease progression in unregulated granuloma formation [74]. Our data showing an increase in CCL2 and TNFalpha in response to M. tuberculosis infection agrees with previous work in murine bone marrow derived macrophages by Kahnert et al. [75].
###end p 97
###begin p 98
###xml 79 94 79 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 117 132 117 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 585 589 585 589 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Young1">[76]</xref>
###xml 591 595 591 595 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0008459-Hussain6">[77]</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 79 94 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 117 132 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 388 395 <span type="species:ncbi:9606">patient</span>
###xml 617 623 <span type="species:ncbi:9606">humans</span>
The differences in chemokine and cytokine responses of TB patients elicited by M. tuberculosis and BCG indicate that M. tuberculosis-specific immune responses remain detectable even in highly endemic populations, where there may be high background responses to environmental mycobacteria. However, such background variability is reflected in the highly variable responses observed in all patient groups as well as in the control groups. Tuberculosis represents an immune spectrum across clinical and subclinical (latent) infection which can only be defined by the host immune response [76], [77]. Clinical studies in humans are therefore limited due to the highly polymorphic and multifactorial nature of the immune responses in a background of variable exposure to cross reactive stimuli.
###end p 98
###begin p 99
###xml 417 432 405 420 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 417 432 <span type="species:ncbi:1773">M. tuberculosis</span>
Overall, these data shows that using CCL2 could provide an adjunct marker of disease severity. In less severe ETB we found the highest IFNgamma responses, but lowest CCL2, TNFalpha and IL10 responses. The coordinate increase in CCL2 and TNFalpha responses observed in the pulmonary TB group, may indicate active monocyte recruitment to the lungs which are likely to facilitate granuloma formation and localization of M. tuberculosis infection. Only CCL2 was increased in severe ETB. Therefore, this suggests that without supportive TNFalpha regulation CCL2 driven leucocyte activation may not be effective. As a consequence, raised CCL2 in itself may be associated with clinical disease severity and dissemination of infection in the host. It is possible that CCL2 may have a better predictive power when combined with other yet unidentified markers. Larger scale studies are required to further define the role of CCL2 in clinical tuberculosis.
###end p 99
###begin title 100
Supporting Information
###end title 100
###begin p 101
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 105 120 105 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 131 132 131 132 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 580 595 580 595 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 64 72 <span type="species:ncbi:9606">patients</span>
###xml 105 120 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 580 595 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 650 658 <span type="species:ncbi:9606">patients</span>
M. tuberculosis- and BCG- induced IL10 and CCL3 responses in TB patients. PBMCs (106) were infected with M. tuberculosis or BCG (106 CFU) for 18 h after which cell supernatants were harvested for the measurement of cytokines and chemokines. The box plots represent the data for each group after the level of cytokine secretion from unstimulated cells was subtracted. The whiskers indicate the 25th and 75th quartiles, while a line indicating the median separates the two. '*' denotes significant differences between groups (p<0.05) using the Mann-Whitney U test. The data show A) M. tuberculosis-induced IL10 (A) and CCL3 (B) responses of PBMCs from patients with pulmonary tuberculosis (PTB, n = 34) and extrapulmonary TB with limited (L-ETB, n = 16) and disseminated (D-ETB, n = 16) disease. BCG-induced IL10 (C) and CCL3 responses (D) were obtained from PTB, n = 33; L-ETB, n = 16; D-ETB, n = 14.
###end p 101
###begin p 102
(5.09 MB TIF)
###end p 102
###begin p 103
Click here for additional data file.
###end p 103
###begin p 104
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 132 147 132 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 680 695 680 695 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M. tuberculosis</italic>
###xml 0 15 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 99 107 <span type="species:ncbi:9606">patients</span>
###xml 132 147 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 680 695 <span type="species:ncbi:1773">M. tuberculosis</span>
###xml 801 809 <span type="species:ncbi:9606">patients</span>
###xml 918 926 <span type="species:ncbi:9606">patients</span>
M. tuberculosis- and BCG-induced CCL3 and CXCL8 mRNA expression in pulmonary and extrapulmonary TB patients. RNA was extracted from M. tuberculosis- or BCG-infected PBMCs after 18 h post stimulation and subjected to RTPCR for chemokine and cytokine genes. Graphs depict fold increase in gene expression after normalization to the housekeeping gene HuPO. Data is depicted as fold increase in each target gene per 100 copies. Box plots depict fold increase in gene expression after normalization to the housekeeping gene HuPO. The whiskers indicate the 25th and 75th quartiles, while a line indicating the median separates the two. '*', p<0.05, indicate differences between groups. M. tuberculosis -induced mRNA expression of A) CCL3, and B) CXCL8 is shown for PTB, n = 22; L-ETB, n = 15, D-ETB, n = 13 patients. BCG-induced mRNA expression of C) CCL3 and D) CXCL8 is shown for PTB, n = 16; L-ETB, n = 14; L-ETB, n = 14 patients.
###end p 104
###begin p 105
(4.85 MB TIF)
###end p 105
###begin p 106
Click here for additional data file.
###end p 106
###begin p 107
###xml 169 176 <span type="species:ncbi:9606">patient</span>
We thank Kausar Naseem, Seema Jamil, Rouknuddin Ali and Muniba Islam for technical assistance. We thank Drs. Ghaffar Dawood, M. Aslam Khan and Javaid Khan for help with patient recruitment.
###end p 107
###begin title 108
References
###end title 108
###begin article-title 109
Global tuberculosis control.
###end article-title 109
###begin article-title 110
Extrapulmonary tuberculosis in immunocompetent adults.
###end article-title 110
###begin article-title 111
Extrapulmonary tuberculosis.
###end article-title 111
###begin article-title 112
###xml 17 45 <span type="species:ncbi:12721">human immunodeficiency virus</span>
Tuberculosis and human immunodeficiency virus infection in developing countries.
###end article-title 112
###begin article-title 113
Immunity to mycobacteria.
###end article-title 113
###begin article-title 114
###xml 35 43 <span type="species:ncbi:9606">patients</span>
Dynamics of cytokine generation in patients with active pulmonary tuberculosis.
###end article-title 114
###begin article-title 115
###xml 65 69 <span type="species:ncbi:10090">mice</span>
Increased antimycobacterial immunity in interleukin-10-deficient mice.
###end article-title 115
###begin article-title 116
###xml 13 33 <span type="species:ncbi:1769">Mycobacterium leprae</span>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Experimental Mycobacterium leprae infection in BALB/c mice: effect of BCG administration on TNF-alpha production and granuloma development.
###end article-title 116
###begin article-title 117
###xml 68 72 <span type="species:ncbi:10090">mice</span>
###xml 123 149 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin.
###end article-title 117
###begin article-title 118
Chemokines and tuberculosis.
###end article-title 118
###begin article-title 119
The many faces of host responses to tuberculosis.
###end article-title 119
###begin article-title 120
Immune responses in tuberculosis.
###end article-title 120
###begin article-title 121
###xml 58 66 <span type="species:ncbi:9606">patients</span>
Differential organization of the local immune response in patients with active cavitary tuberculosis or with nonprogressive tuberculoma.
###end article-title 121
###begin article-title 122
###xml 154 173 <span type="species:ncbi:1765">Mycobacterium bovis</span>
Role of monocyte chemotactic protein-1/CC chemokine ligand 2 on gamma delta T lymphocyte trafficking during inflammation induced by lipopolysaccharide or Mycobacterium bovis bacille Calmette-Guerin.
###end article-title 122
###begin article-title 123
Life and death in the granuloma: immunopathology of tuberculosis.
###end article-title 123
###begin article-title 124
###xml 63 69 <span type="species:ncbi:10090">murine</span>
Role of chemokine ligand 2 in the protective response to early murine pulmonary tuberculosis.
###end article-title 124
###begin article-title 125
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
###end article-title 125
###begin article-title 126
###xml 31 57 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.
###end article-title 126
###begin article-title 127
Chemokines: multiple levels of leukocyte migration control.
###end article-title 127
###begin article-title 128
Purification and amino acid sequencing of NAF, a novel neutrophil-activating factor produced by monocytes.
###end article-title 128
###begin article-title 129
###xml 74 82 <span type="species:ncbi:9606">patients</span>
Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients.
###end article-title 129
###begin article-title 130
Interleukin-8 production in tuberculous pleurisy: role of mesothelial cells stimulated by cytokine network involving tumour necrosis factor-alpha and interleukin-1 beta.
###end article-title 130
###begin article-title 131
Elevated ex vivo monocyte chemotactic protein-1 (CCL2) in pulmonary as compared with extra-pulmonary tuberculosis.
###end article-title 131
###begin article-title 132
Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.
###end article-title 132
###begin article-title 133
ESAT6-induced IFNgamma and CXCL9 can differentiate severity of tuberculosis.
###end article-title 133
###begin article-title 134
Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.
###end article-title 134
###begin article-title 135
Microarray analysis of gene expression associated with extrapulmonary dissemination of tuberculosis.
###end article-title 135
###begin article-title 136
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.
###end article-title 136
###begin article-title 137
###xml 80 106 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
###end article-title 137
###begin article-title 138
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 69 92 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
###xml 112 138 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.
###end article-title 138
###begin article-title 139
###xml 56 82 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach.
###end article-title 139
###begin article-title 140
###xml 57 62 <span type="species:ncbi:9606">human</span>
Identification of tuberculosis susceptibility genes with human macrophage gene expression profiles.
###end article-title 140
###begin article-title 141
Third party evaluation of Expanded Programme on Immunization, Punjab.
###end article-title 141
###begin article-title 142
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 47 59 <span type="species:ncbi:33892">M. bovis BCG</span>
Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
###end article-title 142
###begin article-title 143
Biomarker Changes Associated with Tuberculin Skin Test (TST) Conversion: A Two-Year Longitudinal Follow-Up Study in Exposed Household Contacts.
###end article-title 143
###begin article-title 144
Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.
###end article-title 144
###begin article-title 145
Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns.
###end article-title 145
###begin article-title 146
Country Profile Pakistan.
###end article-title 146
###begin article-title 147
###xml 105 110 <span type="species:ncbi:9606">human</span>
The effect of mycobacterial virulence and viability on MAP kinase signalling and TNF alpha production by human monocytes.
###end article-title 147
###begin article-title 148
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 47 59 <span type="species:ncbi:33892">M. bovis BCG</span>
Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
###end article-title 148
###begin article-title 149
Validation of housekeeping genes for normalizing RNA expression in real-time PCR.
###end article-title 149
###begin article-title 150
Validation of housekeeping genes for normalizing RNA expression in real-time PCR.
###end article-title 150
###begin article-title 151
Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns.
###end article-title 151
###begin article-title 152
###xml 31 57 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.
###end article-title 152
###begin article-title 153
###xml 78 104 78 104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 29 34 <span type="species:ncbi:9606">human</span>
###xml 78 104 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Gene expression profiling of human macrophages at late time of infection with Mycobacterium tuberculosis.
###end article-title 153
###begin article-title 154
IL-10 producing and naturally occurring CD4+ Tregs: limiting collateral damage.
###end article-title 154
###begin article-title 155
###xml 100 126 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
TNF influences chemokine expression of macrophages in vitro and that of CD11b+ cells in vivo during Mycobacterium tuberculosis infection.
###end article-title 155
###begin article-title 156
###xml 27 32 <span type="species:ncbi:9606">human</span>
Expression of IL-8 gene in human monocytes and lymphocytes: differential regulation by TNF and IL-1.
###end article-title 156
###begin article-title 157
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.
###end article-title 157
###begin article-title 158
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 47 59 <span type="species:ncbi:33892">M. bovis BCG</span>
Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
###end article-title 158
###begin article-title 159
###xml 18 44 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
###xml 47 59 <span type="species:ncbi:33892">M. bovis BCG</span>
Differential live Mycobacterium tuberculosis-, M. bovis BCG-, recombinant ESAT6-, and culture filtrate protein 10-induced immunity in tuberculosis.
###end article-title 159
###begin article-title 160
Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development.
###end article-title 160
###begin article-title 161
MIP-1alpha, MIP-1beta, RANTES, and ATAC/lymphotactin function together with IFN-gamma as type 1 cytokines.
###end article-title 161
###begin article-title 162
###xml 31 57 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Beta-chemokines are induced by Mycobacterium tuberculosis and inhibit its growth.
###end article-title 162
###begin article-title 163
###xml 80 106 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
###end article-title 163
###begin article-title 164
###xml 29 34 <span type="species:ncbi:10090">mouse</span>
###xml 69 92 <span type="species:ncbi:33892">Mycobacterium bovis BCG</span>
###xml 112 138 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Transcriptional responses in mouse lungs induced by vaccination with Mycobacterium bovis BCG and infection with Mycobacterium tuberculosis.
###end article-title 164
###begin article-title 165
###xml 56 82 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: a combined transcriptomic and proteomic approach.
###end article-title 165
###begin article-title 166
BCG: the challenge continues.
###end article-title 166
###begin article-title 167
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Demographic characteristics of patients with extrapulmonary tuberculosis in Germany.
###end article-title 167
###begin article-title 168
Comparison of pulmonary and extrapulmonary tuberculosis in Nepal- a hospital-based retrospective study.
###end article-title 168
###begin article-title 169
Ten years of extrapulmonary tuberculosis in a Danish university clinic.
###end article-title 169
###begin article-title 170
###xml 25 33 <span type="species:ncbi:9606">children</span>
Immune function in young children with previous pulmonary or miliary/meningeal tuberculosis and impact of BCG vaccination.
###end article-title 170
###begin article-title 171
Chemokine profiles in the cerebrospinal fluid (CSF) during the course of pyogenic and tuberculous meningitis.
###end article-title 171
###begin article-title 172
Cytokine polarization in miliary and pleural tuberculosis.
###end article-title 172
###begin article-title 173
Pathophysiology and prognosis in vietnamese adults with tuberculous meningitis.
###end article-title 173
###begin article-title 174
Pulmonary tuberculosis in a BCG vaccinated area: relationship of disease severity with immunological and hematological parameters and drug resistance patterns.
###end article-title 174
###begin article-title 175
Interferon gamma/IL10 ratio defines the disease severity in pulmonary and extra pulmonary tuberculosis.
###end article-title 175
###begin article-title 176
###xml 49 75 45 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 49 75 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
An essential role for IFN-gamma in resistance to Mycobacterium tuberculosis infection.
###end article-title 176
###begin article-title 177
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.
###end article-title 177
###begin article-title 178
Severe tuberculosis induces unbalanced up-regulation of gene networks and overexpression of IL-22, MIP-1alpha, CCL27, IP-10, CCR4, CCR5, CXCR3, PD1, PDL2, IL-3, IFN-beta, TIM1, and TLR2 but low antigen-specific cellular responses.
###end article-title 178
###begin article-title 179
###xml 66 92 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection.
###end article-title 179
###begin article-title 180
###xml 59 85 59 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mycobacterium tuberculosis</italic>
###xml 21 27 <span type="species:ncbi:10090">murine</span>
###xml 59 85 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
TNF-dependent BALB/c murine macrophage apoptosis following Mycobacterium tuberculosis infection inhibits bacillary growth in an IFN-gamma independent manner 41.
###end article-title 180
###begin article-title 181
###xml 80 106 <span type="species:ncbi:1773">Mycobacterium tuberculosis</span>
Alternative activation deprives macrophages of a coordinated defense program to Mycobacterium tuberculosis.
###end article-title 181
###begin article-title 182
Eliminating latent tuberculosis.
###end article-title 182
###begin article-title 183
Longitudinal tracking of cytokines after acute exposure to tuberculosis: association of distinct cytokine patterns with protection and disease development.
###end article-title 183
###begin p 184
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 184
###begin p 185
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
###xml 79 87 <span type="species:ncbi:9606">Children</span>
Funding: This investigation received financial support from the United Nations Children's Fund (UNICEF)/United Nations Development Programme (UNDP)/World Bank/World Health Organization (WHO) and was funded by the Special Programme for Training in Tropical Diseases Research, TDR, WHO. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 185

